Nifedipine Ennogen Ip (Nifedipine)

Nifedipine blocks L‑type calcium channels in arterial smooth‑muscle cells, preventing calcium entry that is required for contraction. This inhibition produces dose‑dependent vasodilation, reduces peripheral vascular resistance, and lowers arterial pressure. In coronary vessels, the same mechanism enhances myocardial oxygen delivery, alleviating ischemic chest pain.

The specific dose of Nifedipine Ennogen Ip is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other concurrent medications. Healthcare professionals tailor the regimen to achieve optimal blood‑pressure control or angina relief while minimizing adverse effects.

Safety data for nifedipine in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements), and required import documentation.

Nifedipine belongs to the dihydropyridine class, which primarily causes arterial vasodilation. Compared with amlodipine, another dihydropyridine, nifedipine has a shorter half‑life and may require more frequent dosing. Both agents lower blood pressure, but nifedipine can produce more pronounced reflex tachycardia, whereas amlodipine’s longer action often results in smoother blood‑pressure control.

Nifedipine Ennogen Ip should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use. Do not store in a refrigerator or freezer.

The medication is taken orally. Patients should swallow the tablet whole with a full glass of water, preferably at the same time each day to maintain consistent plasma levels. It can be taken with or without food, but patients should follow any specific instructions provided by their prescriber.

The most serious adverse events include severe hypotension, which can lead to fainting or shock; myocardial infarction, particularly in patients with existing coronary artery disease; and atrioventricular (AV) block, a rare but potentially life‑threatening conduction disturbance. Prompt medical attention is required if any of these symptoms occur.

Nifedipine is contraindicated in patients with severe hypotension, cardiogenic shock, recent myocardial infarction, unstable angina, or significant aortic stenosis. Individuals with known hypersensitivity to nifedipine or any other dihydropyridine calcium channel blocker should also avoid this medication.